A Long-Term Prospective Evaluation of the Predictive Value of Molecular Markers in Serum and Cerebrospinal Fluid in Patients in the Early Stage of Multiple Sclerosis
= 0.014, respectively). High levels of NfLs and Il6 in the CSF of MS patients assessed before the therapy may be an indication to use a highly effective therapy as the first treatment for MS.
Authors
- Małgorzata Domowicz (ORCID: https://orcid.org/0000-0002-7804-9926)
- Magdalena Oset (ORCID: https://orcid.org/0000-0002-3126-5082)
- Magdalena Namiecińska (ORCID: https://orcid.org/0000-0002-6874-4992)
- Mariola Matysiak (ORCID: https://orcid.org/0000-0002-6779-308X)
- Mariusz Stasiołek (ORCID: https://orcid.org/0000-0002-2582-1708)
- Dominika Świerczewska (ORCID: https://orcid.org/0009-0006-3007-5638)
- Karolina Pendrasik (ORCID: https://orcid.org/0009-0007-3591-4864)
Institutions
- Medical University of Lodz (PL)
Publication Details
- Journal
- International Journal of Molecular Sciences
- Published
- 2026-03-31
- DOI
- https://doi.org/10.3390/ijms27073155
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00